New antibody drug aims to cut COPD attacks in half
NCT ID NCT06789289
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 2 trial tests TQC2938, a lab-made antibody, in 256 people with moderate to severe COPD. The goal is to see if the drug can reduce the number of serious flare-ups over 24 weeks compared to a placebo. Participants receive injections and are monitored for safety and side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
TQC2938 (a lab-made antibody that blocks certain signals in the body)
What this could lead to
If it works, this could lead to a new treatment that reduces the number of serious COPD flare-ups, helping patients breathe easier and stay out of the hospital.
What could go wrong
This is a mid-stage trial with only 256 people, so results may not apply to everyone. The drug is still experimental, and side effects or lack of benefit are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Hospital Of ChengDu University
Chengdu, Sichuan, 610081, China
-
Affiliated Hospital of Jiangsu University
Zhenjiang, Jiangsu, 212050, China
-
An Hui Chest Hospital
Hefei, Anhui, 230000, China
-
Cangzhou Central Hospital
Cangzhou, Hebei, 061000, China
-
China-Japan Friendship Hospital
Beijing, Beijing Municipality, 100029, China
-
Henan Chest Hospital
Zhengzhou, Henan, 450000, China
-
Heze Municipal Hospital
Heze, Shandong, China
-
Jiangmen Central Hospital
Jiangmen, Guangdong, 529000, China
-
Jiangxi Provincal People's Hospital
Nanchang, Jiangxi, 330000, China
-
Jinhua Municipal Centeral Hospital Medical Group
Jinhua, Zhejiang, 321000, China
-
Leshan People's Hospital
Leshan, Sichuan, 614099, China
-
Linfen Central Hospital
Linfen, Shanxi, 041099, China
-
Liuzhou municipal liutie central hospital
Liuzhou, Guangxi, 545007, China
-
Meihekou Central Hospital
Meihekou, Jilin, 135000, China
-
Peking University First Hospital
Beijing, Beijing Municipality, 100034, China
-
Peolpe's Hospital Of Chongqing Banan District
Chongqing, Chongqing Municipality, 400054, China
-
Puyang Oilfield General Hospital
Puyang, Henan, 457001, China
-
Shanghai JiaoTong University of medicine Ruijin Hospital
Shanghai, Shanghai Municipality, 20025, China
-
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, 200433, China
-
Shaoyang Central Hospital
Shaoyang, Hunan, 422000, China
-
Shunde Hospital Of Southern Medical University
Foshan, Guangdong, 528308, China
-
Siping Central People's Hospital
Siping, Jilin, 136099, China
-
Suining Central Hospital
Suining, Sichuan, 629000, China
-
Taizhou Hospital Of Zhejiang Province
Taizhou, Zhejiang, 318000, China
-
The 2th School of Medicine ,WMU/The 2th affiliated Hospital and Yuying Children's Hospital of WMU
Wenzhou, Zhejiang, 325027, China
-
The Affiliated Hospital of Mongolia Medical College
Hohhot, Inner Mongolia, 010000, China
-
The First Affiliated Hospital of Jiamusi University
Jiamusi, Heilongjiang, 154003, China
-
The First Affiliated Hospitial Of Ningbo University
Ningbo, Zhejiang, 315211, China
-
The First Hospital of Qiqihar
Qiqihar, Heilongjiang, 161005, China
-
The First People' Hospital Of YuLin
Yulin, Guangxi, 537000, China
-
The First People's Hospital of Xinxiang City
Xinxiang, Henan, 453000, China
-
The Fourth Central Hospital of Tianjin
Tianjin, Tianjin Municipality, 300140, China
-
The Third People's Hospital of Xinjiang Uygur Autonomous Region
Ürümqi, Xinjiang, 830091, China
-
The second hospital of hebei medical university
Shijiazhuang, Heibei, 05000, China
-
The second xiangya hospital of central south university
Changsha, Hunan, 410011, China
-
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, 300041, China
-
Weifang NO.2 People' Hospital
Weifang, Shandong, 261041, China
-
Xi'An International Medicl Center Hospital
Xi’an, Shanxi, 710061, China
-
Xingtai People's Hospital
Xingtai, Hebei, 54000, China
-
Yongcheng People's Hospital
Yongcheng, Henan, 476600, China